1. Home
  2. MTC vs BLUE Comparison

MTC vs BLUE Comparison

Compare MTC & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTC
  • BLUE
  • Stock Information
  • Founded
  • MTC 2015
  • BLUE 1992
  • Country
  • MTC Hong Kong
  • BLUE United States
  • Employees
  • MTC N/A
  • BLUE N/A
  • Industry
  • MTC Computer Software: Prepackaged Software
  • BLUE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MTC Technology
  • BLUE Health Care
  • Exchange
  • MTC Nasdaq
  • BLUE Nasdaq
  • Market Cap
  • MTC N/A
  • BLUE 36.9M
  • IPO Year
  • MTC 2019
  • BLUE 2013
  • Fundamental
  • Price
  • MTC $1.17
  • BLUE $3.71
  • Analyst Decision
  • MTC
  • BLUE Hold
  • Analyst Count
  • MTC 0
  • BLUE 7
  • Target Price
  • MTC N/A
  • BLUE $44.60
  • AVG Volume (30 Days)
  • MTC 84.6K
  • BLUE 144.2K
  • Earning Date
  • MTC 05-13-2025
  • BLUE 05-16-2025
  • Dividend Yield
  • MTC N/A
  • BLUE N/A
  • EPS Growth
  • MTC N/A
  • BLUE N/A
  • EPS
  • MTC N/A
  • BLUE N/A
  • Revenue
  • MTC $1,868,333.00
  • BLUE $83,807,000.00
  • Revenue This Year
  • MTC N/A
  • BLUE $218.58
  • Revenue Next Year
  • MTC N/A
  • BLUE N/A
  • P/E Ratio
  • MTC N/A
  • BLUE N/A
  • Revenue Growth
  • MTC N/A
  • BLUE 184.12
  • 52 Week Low
  • MTC $0.18
  • BLUE $3.56
  • 52 Week High
  • MTC $12.90
  • BLUE $28.60
  • Technical
  • Relative Strength Index (RSI)
  • MTC 56.61
  • BLUE 36.39
  • Support Level
  • MTC $1.14
  • BLUE $3.62
  • Resistance Level
  • MTC $1.27
  • BLUE $4.45
  • Average True Range (ATR)
  • MTC 0.09
  • BLUE 0.25
  • MACD
  • MTC 0.01
  • BLUE -0.04
  • Stochastic Oscillator
  • MTC 72.50
  • BLUE 9.47

About BLUE bluebird bio Inc.

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

Share on Social Networks: